Regulatory and coding variants are known to be enriched with associations identified by genome-wide association studies (GWASs) of complex disease, but their contributions to trait heritability are currently unknown. We applied variance-component methods to imputed genotype data for 11 common diseases to partition the heritability explained by genotyped SNPs (h 2 g ) across functional categories (while accounting for shared variance due to linkage disequilibrium). Extensive simulations showed that in contrast to current estimates from GWAS summary statistics, the variance-component approach partitions heritability accurately under a wide range of complex-disease architectures. Across the 11 diseases DNaseI hypersensitivity sites (DHSs) from 217 cell types spanned 16% of imputed SNPs (and 24% of genotyped SNPs) but explained an average of 79% (SE ¼ 8%) of h 2 g from imputed SNPs (5.13 enrichment; p ¼ 3.7 3 10 À17 ) and 38% (SE ¼ 4%) of h 2 g from genotyped SNPs (1.63 enrichment, p ¼ 1.0 3 10
Introduction
Recent work by ENCODE and other projects 1, 2 has shown that specific classes of variants can have complex and diverse impacts on cell function and phenotype. [3] [4] [5] [6] [7] [8] [9] [10] Although the importance of coding variation has long been understood, these projects identified other genomic regions that can contribute to function and highlighted the role of regulatory variants. With many potentially informative functional categories and competing biological hypotheses, quantifying the contribution of variants in these categories to heritability of complex traits would inform trait biology and focus genetic mapping. The availability of significantly associated variants from hundreds of genome-wide association studies (GWASs) 11 has opened one avenue for quantifying enrichment. Indeed, 11% of GWAS hits lie in coding regions, 11 57%
of noncoding GWAS hits lie in broadly defined DNaseI hypersensitivity sites (DHSs; spanning 42% of the genome), 3 and still additional GWAS hits tag these regions. The full distribution of GWAS association statistics exhibits enriched p values in coding regions and UTRs. 12 Analysis of DHS subclasses and other histone marks has revealed a complex pattern of cell-type-specific relationships with known disease associations. 6 Recent work has also shown that functional enrichment can be leveraged for increasing association mapping power. 13 Although relative enrichment has been documented, the question of how much each category contributes to disease heritability remains unanswered. 14, 15 Recently, investigators have used variance-component methods to estimate the total additive variance explained by all genotyped SNPs (h 2 g ), 16, 17 and to estimate the h 2 g of many quantitative and dichotomous traits. [18] [19] [20] [21] [22] We propose joint estimation of h 2 g from functional-category-specific variance components for assessing enrichment. In contrast to analyses of top GWAS hits, the variance-component approach leverages the entire polygenic architecture of each trait and accounts for pervasive linkage disequilibrium (LD) across functional categories. Indeed, our simulations showed that this approach provides accurate genome-wide estimates of functional enrichment in diverse genetic architectures. We applied variance-component methods to functional categories in GWAS-and exome-chip data from over 100,000 samples in 11 traits.
Material and Methods

Estimating Enrichment of h 2 g with Variance Components
For a single component of genotyped (or imputed) SNPs, we define h 2 g , an underlying parameter in the population, as the r 2 between the true phenotype and the best linear prediction over those SNPs. With multiple components, the goal of the partitioned analysis is to quantify the h ) by using the liabilitythreshold model, in which individuals whose underlying unobserved continuous liability exceeds a threshold are labeled as disease case subjects. 19, 23 We estimate h 2 g jointly across multiple variance components, each constructed from variants belonging to nonoverlapping functional categories. The underlying model assumes that SNP effect sizes are drawn from a normal distribution with categoryspecific variance. (We note that the normality assumption is unrealistic; previous work in the single-variance-component case has indicated that this does not introduce bias, although modeling a more realistic mixture distribution can increase precision. 24 Because of computational constraints, we do not consider mixture distributions here.) The model relates the observed phenotypic covariance to a weighted sum of genetic relationship matrices computed from SNPs in each category. The joint estimate allows all components to compete for shared variance due to LD.
Formally, for a functional categories each containing the set of SNPs S i (of size M i ), we model the phenotype as a sum of individual SNP effect sizes:
where W s is the genotype at SNP s, b i s is the effect size at SNP s in category i and is drawn from category-specific normal distribution b i $ Nð0; s 2 i Þ, and e is the residual effect e $ Nð0; s 2 e Þ. We assume that for each annotation i, SNPs normalized to have mean 0 and variance 1 are contained in the matrix W i . The variance of the phenotype is then modeled as
where each K i represents a genetic-relationship matrix (GRM) computed directly from the SNPs in annotation i as
The corresponding s are then jointly inferred with the REML algorithm in GCTA (Genome-wide Complex Trait Analysis), 16, 17 yielding
The inverse of the final average-information matrix yields an estimate of the corresponding error-covariance matrix of the variance-component estimates. 25 We use the error-covariance matrix and delta method 26 to compute SEs on h 2 g and the percentage of h 2 g while accounting for error correlations (referred to here as the analytical SE 27 ). All estimates of h 2 g were transformed to the liability scale 19 with the prevalence values in Table S1 (available   online) . We evaluated the accuracy of the analytical SE for both quantitative and ascertained traits and found it to correspond well to the true SD under reasonable polygenicity (see Appendix A). Meta-analysis estimates were computed with inverse-variance weighting: 28 given individual study estimates h 2 gi , analytical SE i , and corresponding weight w i ¼ 1=SE 2 i , the meta-analysis mean is equal to
and the meta-analysis SE is equal to ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi 1= P i w i p . Enrichment is computed for each category i as the ratio of the percentage of h 2 gi (the percentage of h 2 g in category i) to the percentage of SNP i (the percentage of SNPs in category i) and is tested for significance by Z score relative to a null of 1:0 with the (likewiserescaled) analytical SE. Under the assumption that all causal variants are typed, this statistic is equivalent to the relative risk that a SNP in category i is causal in comparison to an average SNP. To achieve unbiasedness, the estimate of h 2 g is not constrained to lie inside the plausible 0-1 bound, which can lead to negative estimates in rare instances.
Estimating Enrichment from Summary Statistics
We considered alternative methods for estimating functional enrichment from summary association statistics. The simplest approach is to directly count the number of individual genomewide-significant variants in each functional annotation and compare to the null expectation from all SNPs (or random SNPs matched on certain features). This approach can either include all significant markers or restrict to the most significant variant in each locus. The genome-wide-significant-SNP approach has been extended to the full distribution of association statistics for quantifying overall p value enrichment. 3 Over increasingly restrictive p value thresholds, the fraction of SNPs passing a given threshold and belonging to each category is computed and normalized by the category-specific genome-wide fraction. The distributions are then inspected visually for enrichment or assessed by permutation. For completeness, we considered two additional methods-stratified quantile-quantile (Q-Q) plots 12 and Bayesian hierarchical modeling (fgwas) 13 -which assess functional enrichment but are primarily focused on improving association mapping power (see Discussion).
Data Sets Analyzed
Diseases from WTCCC1 and WTCCC2
We analyzed seven traits from Wellcome Trust Case Control Consortium 1 (WTCCC1) and four traits from WTCCC2 for a total 47,000 samples (Table S1) Markers with an information (info) score greater than 0.5 were retained. Finally, SNPs were excluded if they met any of the following criteria in any case or control population: Hardy-Weinberg p value < 0.05, per-locus missingness > 0.05, MAF < 0.01, or case-control differential missingness p value < 0.05.
Schizophrenia Cohort from the Psychiatric Genomics Consortium
We analyzed 24,926 schizophrenia (SP) subjects and 33,271 control individuals from 33 cohorts from the Psychiatric Genomics Consortium (PGC2); they were typed on a variety of platforms, quality controlled, and imputed to the 1000 Genomes reference panel as previously described 35 (Tables S1 and S2 ). Because of computational constraints, we split the cohort into four subgroups of individuals typed on similar platforms; each contained roughly 10,000-20,000 samples. We performed all analyses on the intersection of well-imputed SNPs within each subgroup, ranging from four to five million, and reported meta-analyzed results. Individual study identifiers and 20 multidimensional-scaling components were included as fixed-effect covariates in all analyses.
Swedish SP Exome Chip
We analyzed 12,674 Swedish samples typed on GWAS and exome chips (Tables S1 and S3 ). The exome chip yielded 238,652 SNPs (including monomorphic sites), of which 10,567 were also typed on a mix of Affymetrix GWAS chips (exome-chip calls were retained). The GWAS-chip data contained an intersection of 163,051 SNPs typed on all platforms in addition to per-platform imputation from 1000 Genomes for a total of 5,053,934 SNPs imputed on all platforms. Principal-component analysis (PCA) of the GWAS data revealed a large cluster of ''homogenous'' Swedish samples and clines related to Northern Swedish and Finnish admixture ( Figure S2 ). After excluding samples that (1) were not typed on both GWAS and exome chips, (2) failed QC, (3) were PCA outliers by 6 SDs, or (4) were in a pair with GRM values > 0.05 (close relatives), we retained a total of 8,967 samples, of which 6,375 were of ''homogenous'' Swedish ancestry. In all of our analyses, rare variants had a MAF < 0.01, and common variants had a MAF R 0.01. Simulations were performed on the homogenous samples (without principal components). We performed analyses of real phenotypes on the homogeneous samples and included the top 20 principal components as covariates (to account for any residual population structure; analyses on the full cohort are reported in Tables S23 and S25 ).
Functional Annotations
We annotated the genome by using six primary categories (Table  S4) : (1) coding, (2) UTR, (3) promoter, (4) DHS in any of 217 cell types, (5) intronic, and (6) intergenic. Each SNP was then assigned a unique annotation defined by the first of these categories with which it was annotated, resulting in six nonoverlapping variance components (the DHS category was thus restricted to distal regions). Each resulting category exhibited similar average allele frequency and imputation accuracy, although the DHS category had systematically lower LD 36 (Table S5 ). We also computed the ''effective'' number of SNPs in each category by using an LD-based metric that does not depend on sample size. 36, 37 
Simulation Framework
The goal of our simulations was to demonstrate that the partitioned h 2 g properly recovers the heritability explained by causal variants in a given functional category under a variety of disease architectures. We performed simulations in genotyped and imputed data in 4,414 samples from the WTCCC1 coronary artery disease (CAD) case-control cohort together with the six main functional annotations to evaluate robustness and accuracy of the proposed variance-component method and the p-valueenrichment approach; we note that the genome-wide-significant-SNP approach is subsumed by the latter and is not reported separately in most analyses. For each simulation, 10% of the (genotyped or imputed) SNPs were randomly sampled to be causal, and normally distributed effect sizes were assigned to each SNP such that each explained equal variance in expectation. Additive phenotypes were then constructed, and random noise was added for an overall h 2 g of 0.50. Except when evaluating h 2 g between genotyped and imputed SNPs, we did not hide causal variants from the analyses, corresponding to the assumption that all causal variants are typed. We evaluated the variance-component model by using multiple components with GCTA in the unconstrained mode. For approaches based on summary statistics, we computed Z scores, SEs, and p values for the univariate regression of each SNP to a simulated phenotype.
Results
Simulations
We first evaluated the calibration of the methods in simulations of no enrichment by assuming a MAF-independent architecture where causal variants were uniformly sampled from the genome (see Material and Methods). We observed no significant deviations from the null for any categories estimated by variance components or p value enrichment ( Figure 1 ). To evaluate possible biases due to MAF-dependent architectures, 21, 41, 42 we also considered a low-frequency architecture where only SNPs with a MAF below 0.05 can be causal and a DHS-low-frequency architecture where causal DHS variants are drawn from MAF below 0.05 and all other variants are drawn from any MAF (Figures S3 and S4). Results were generally similar to the MAF-independent architecture, although variance-component estimates exhibited slight but statistically significant deviations for the promoter and UTR categories, which were very small and in tight LD with each other. We next considered simulations with maximal enrichment, where all causal variants were drawn from a single functional category. MAF-independent results for the coding and DHS categories are shown in Figure 2 (see Figure S5 for other results). The variance-component estimate of the percentage of h 2 g was again around 100% for the true causal category and 0% for all others. The plots of p value enrichment correctly demonstrated significant enrichment for five of the categories, but not the DHS category, which, when causal, was not significantly different from the null. This lack of enrichment at DHSs and not at other large categories was most likely due to the uniquely lower LD of DHS SNPs (Table S5 ). For the small categories (coding, UTR, and promoter), true causals in one category always yielded false p value enrichment in the others because of their close proximity and high LD (Figure 2 ; Figures S6 and S7). In the MAF-dependent scenarios, the variance-component estimate of h 2 g was nearly unbiased: it had slight but significant inflation at the coding and UTR categories when they contained 100% of h 2 g ( Figure S8 ). Plots of p value enrichment exhibited similar patterns as in the MAF-independent simulations, and the DHS category was further falsely depleted ( Figure S7 ).
To investigate the differences between genotype-and imputation-based estimates, we partitioned h 2 g of category-specific phenotypes simulated from imputed SNPs by using components constructed from genotyped SNPs only. If the genotypes are reasonable proxies for imputed variants, 100% of h 2 g should again be partitioned into each truly causal category. Instead, we observed significant deviations for all of the categories, and h 2 g was partitioned into nearby categories as a result of incomplete tagging (Figures S9 and S10). In particular, less than half of the h 2 g at imputed DHSs was partitioned into the DHS category in genotype data. Thus, estimates produced with only genotyped SNPs can severely underestimate enrichment. The difference between genotyped and imputed simulations suggests that estimates from imputed SNPs could also underestimate the true enrichments or depletions for rare causal variants that are absent from 1000 Genomes or are poorly imputed. We investigated this possibility by using the exome-chip SP data (see below). We separately assessed the impact of imputation error by simulating phenotypes with induced genotype noise proportional to the per-SNP imputation quality score (info score; Supplementary information S3 in Marchini et al. 43 ) but observed no significant biases in null or causal simulations (Tables S8 and S9) , most likely as a result of the stringent postimputation QC. We evaluated multiple other complex architectures with respect to LD (see Appendix A) but observed significant bias in only one deliberately severe scenario: causal variants sampled from intronic and intergenic regions either directly adjacent to or proximal to a DHS (within 1 kb of a DHS boundary). Although no substantial false DHS heritability was observed in genotyped SNPs, the imputed DHS component picked up 50% (0-500 bp) and 20% (500-1,000 bp) of the non-DHS h 2 g ( Figure S11 ). Given our findings that genotyped SNPs are expected to greatly underestimate DHS enrichment, we consider genotyped and imputed estimates to be lower and upper bounds, respectively, on the true causal enrichment.
Heritability of Functional Categories across 11 Diseases
We analyzed a total of 11 WTCCC1 and WTCCC2 phenotypes. [44] [45] [46] After QC, 21 the seven WTCCC1 traits each included an average of 1,700 affected subjects and a set of 2,700 shared control subjects; the four WTCCC2 traits included 1,800-9,300 affected subjects and 5,300 shared control subjects (see Material and Methods; Table S1 ). In all analyses of autoimmune traits, SNPs in the well-studied MHC region were excluded, although inclusion of the MHC as a separate component did not significantly affect the results. Each cohort was imputed to the 1000 Genomes reference panel, yielding four to six million SNPs per trait after QC (see Material and Methods; Table S1 ). This analysis is expected to be skewed toward the autoimmune traits, which composed 6/11 traits analyzed and 20,461/ 30,158 affected subjects analyzed. We computed metaanalysis values by using inverse-variance weighting with the analytical SE to account for different levels of error across h 2 g estimates. After meta-analysis, resulting SEs were adjusted for the use of shared controls by genomic control (unless otherwise stated), and p values were computed by a simple Z score comparing the mean enrichment and adjusted SE to a null of 1.0 enrichment. Estimating enrichment from shifted functional annotations yielded null enrichments and p values (Tables S10 and S11), confirming that this null is comparable to random SNP comparisons used in previous work. 3, 11, 40, 47 Combined results meta-analyzed across all traits are reported in Figure 3 (Tables S10, S12, and S13). In genotyped data, DHS variants (spanning 24% of genotyped SNPs) were the most significantly enriched and explained an average of 38% (SE ¼ 4%) of the total h 2 g , a 1.63 enrichment (p ¼ 1.0 3 10 À4 ). Coding variants were the only other category significantly enriched (after six tests were accounted for) and explained 4% (SE ¼ 1%; p ¼ 1.1 3 10 À3 ). All enrichments or depletions were stronger when imputed SNPs were analyzed in terms of both significance and information content, consistent with our previous simulations (Figures S9 and S10; 21 but it can more precisely partition heritability into functional categories. We performed additional simulations mimicking the enrichment observed in imputed data with 8,300 causal variants (as inferred in a large GWAS of a polygenic trait 48 ) and found that 79% of heritability was explained by imputed DHS SNPs, 8% was explained by imputed coding SNPs, and the remainder was uniformly drawn from the other variant categories. This ''realistic'' scenario yielded much weaker estimates of enrichment from genotyped SNPs, and they were similar to estimates from genotyped SNPs in real data ( Figure 3 ). We considered alternative estimation procedures to rule out potential biases. Although we allowed individual values of h 2 g to fluctuate outside the 0-1 bound on variance to achieve unbiased estimates prior to averaging across traits, 49 a constrained analysis yielded similar results (see Table S15 ). Individual point estimates escaping the 0-1 bound were consistent with our imputed simulations under realistic enrichment, which showed that the percentage of h 2 g for DHSs exceeded 1.0 10% of the time, whereas the percentage of h 2 g for intronic and intergenic regions fell below 0.0 30% and 23% of the time, respectively, for a typical 7,000-sample cohort. Using flat instead of inverse-variance weighting yielded a comparable estimate such that DHS SNPs explained an average of 85% (SE ¼ 15%) of h 2 g . With the flat weighting, the SD of imputed DHS estimates across different traits was 48%, which corresponds to a SD of 32% in the true unobserved values after the analytical SE of each estimate is accounted for (Table S14) . We further evaluated the robustness of these estimates and found that biases arising from analytical SEs, ancestry, or case-control ascertainment were unlikely to significantly affect the enrichment (see Appendix A).
To investigate whether enrichment in h 2 g from all SNPs at known loci was consistent with the genome-wide estimates, we partitioned the h 2 g explained by SNPs within 1 Mb of published GWAS loci for each trait (NHGRI GWAS catalog; 11 see Web Resources) ( Figure S13 ). Because some traits had a small number of loci, the DHS component was jointly analyzed with only a single other component containing all non-DHS SNPs. We again observed a highly significant DHS enrichment in imputed data and a significant difference between the genotyped and imputed estimates lay in our DHS annotation, yielding a comparable 1.83 noncoding enrichment. Extending to the full distribution of association statistics did not reveal significant DHS enrichment in any of these traits ( Figure 4 , left panel; Figure S14 ). This is consistent with our previous simulations showing the variance-component approach to be more effective than the p-value-enrichment approach at identifying DHS enrichment from complex-disease architectures ( Figure 2) . We sought to further confirm this observation by extending our simulations to a single large cohort with realistic levels of enrichment on the basis of the above results. We simulated the ''realistic'' level of enrichment (see above) in 33,000 combined WTCCC2 samples, corresponding to a large GWAS. We then conducted a standard GWAS on the simulated traits and plotted functional enrichment by using p value enrichment (see Material and Methods). The strategy yielded enrichment at coding Figure 4, middle panel) . However, proximal categories such as UTR and promoter, which were truly depleted, also appeared enriched through tagging of significant coding variants. DHS variants were the least-enriched nonintergenic category, even though they made the single largest contribution to heritability. This was likely due to lower power to detect DHS SNPs as a result of their lower average effect size (relative to that of coding SNPs) and less LD. On the other hand, applying the variance-component strategy to the simulated cohorts correctly recovered the enrichment factors (Figure 4, right panel) . These simulations further demonstrate that GWAS p values, although partially informative, can yield false-positive and falsenegative enrichment to make functional interpretation difficult, motivating further development of methods that can produce robust estimates of partitioned heritability from summary statistics.
Analysis of PGC2 SP Data
We replicated our functional-enrichment results in an independent cohort of 58,197 samples from PGC2 (Tables  S1 and S2 ). In the PGC2 data, the imputed DHS enrichment was significant at 3.23 (SE ¼ 0.29, p ¼ 1.4 3 10 À13 ), and the intergenic category was significantly depleted at 0.33 (SE ¼ 0.06, depletion p < 1 3 10 À20 ; Table   S18 Table S14 ). The consistency of WTCCC2 and PGC2 estimates indicates that platform artifacts are unlikely to be a major confounder. Moreover, the substantially lower SE in this large cohort demonstrates the effectiveness of our methods at characterizing a single complex trait. As in our previous simulations, p value enrichment did not identify substantial enrichment at DHS variants ( Figure S15 ).
Partitioning h 2 g within DHSs
We further partitioned DHS enrichment in the WTCCC1 data into functional subcategories to assess significance in relation to all DHSs. We used Segway-chromHMM combined classifications of enhancer regions 40 to partition DHSs (15.7% of the genome) into those that overlapped predicted enhancers (3.2% of the genome) and those that did not ( Figure 5A ). The enhancer DHSs explained 31.7% (SE ¼ 3.3%) of the total h 2 g , yielding an enrichment of 9.83 versus all SNPs (1.93 versus all DHSs; p ¼ 5.1 3 10 À4 ). We also partitioned DHSs into regions that were called in two or fewer cell types (''specific''; after merging similar tissues) and those that were not ( Figure 5B ). We observed a significant enrichment for cell-type-specific DHSs (6.13 versus all SNPs; 1.33 versus all DHSs; p ¼ 3.2 3 10 À3 ). The enrichment was not significant when we repeated this analysis for enhancer and nonenhancer DHSs separately. We next split the DHSs into SNPs overlapping and not overlapping the ENCODE database of DGF regions (8.5% of the genome), which are expected to precisely map sites where regulatory factors bind to the genome 50 ( Figure 5C ). We observed no difference in h between these DHSs and other DHSs (1.03, p ¼ 0.90). However, DGF annotations were collected for only a subset of DHS cell types analyzed, and analysis in additional cell types is needed. Lastly, we partitioned the h 2 g by using an expanded DHS annotation (including regions overlapping coding regions, UTRs, and promoters) into the remaining five major categories (Table S19) we assessed enrichment in relation to all DHSs. On the basis of our previous observation of heterogeneity, we performed meta-analyses across the six autoimmune traits (excluding the MHC) and across the five nonautoimmune traits. We observed seven cell types that were significantly enriched in autoimmune traits in genotype data (we conservatively adjusted for 83 tests, although the cell types are highly correlated), and none were significantly enriched in nonautoimmune traits ( Table 1) . Four of these seven cell types have previously been implicated in autoimmune diseases: Trynka et al. 6 found that GWAS hits for RA were enriched within H3K36me3 peaks from CD8 þ primary cells (at p ¼ 0.0042), and Maurano et al. 3 found that nominally significant SNPs in a GWAS of CD were enriched within DHS peaks from primary T helper 1 cells and that nominally significant SNPs in a GWAS of MS were enriched in DHS peaks from lymphoblastoid and monocyte CD14 þ cells. The remaining three significant cell types were leukemia cells, fetal pelvis cells, and fetal thymus cells (additional nominally significant cell types are listed in Table S20 ). The enrichment was typically observed in all autoimmune traits individually; CD was the least enriched on average (2.83), and UC was the most enriched on average (5.13; Table S21 ). As before, the signal was stronger and more significant when we included imputed SNPs (Table 1) . On the basis of the hypothesis that most regulatory sites lie at the center of the called DHS peaks, we considered the enrichment after progressively narrowing the DHS annotations. Specifically, we trimmed the ends of each DHS peak (without removing any individual peaks) to a maximum length set such that the resulting overall DHS annotation covered 1%, 5%, or 10% of the physical genome. We then tested these three narrowed annotations in two models: (1) a univariate model in which h 2 g was inferred from only the narrowed DHS component, thereby including any tagged heritability from other functional categories; and (2) a six-component model in which the full DHS component was replaced with the narrowed DHS component and the remaining DHS SNPs were distributed into the intron and other components. We found the DHS centers to be particularly strongly enriched (Table S22) ; the 1% annotation explained 19.8% of the total h g from narrowed annotations is further evidence of enrichment at the DHS centers. We caution that this experiment might have been particularly susceptible to bias from causal variants very close to the annotation boundary.
Unbiased Estimates of h 2 g with Rare and Common Variants We separately analyzed a cohort of 2,500 SP subjects and 3,875 control subjects who were of homogenous Swedish origin and had been typed on both GWAS and exome chips (see Material and Methods; Tables S1 and S3) to investigate the possible contribution of rare coding variants to missing heritability, 51 defined as the gap between our genome-wide estimates of h 2 g and the total narrowsense heritability. The exome-chip variants were primarily rare and consisted of 18% singletons and 64% nonsingletons with a MAF below 0.01. A concern is that h 2 g estimates from exome-chip data can be substantially biased as a result of the abundance of rare variants. 21, 41, 42 To address this, we performed simulations across the full causal-allele frequency spectrum and found that joint estimates from two frequency-stratified 42 components computed from rare (MAF % 0.01) and common (MAF > 0.01) SNPs eliminated most of the observed bias. Subsequently adjusting each component for LD completely eliminated bias for normalized effect sizes ( Figure S17 ) and yielded the most accurate estimate for standard effect sizes ( Figure S18 ). We report estimates from joint components with (Table 2) and without (Table S23 ) LD adjustment. We partitioned the heritability explained by GWAS-chip and exome-chip data into three separate variance components: noncoding, rare coding (MAF < 0.01), and common coding variants. This partitioned analysis identified a total h 2 g of 0.079 (SE ¼ 0.034) from all coding variants (Table 2) ; only the h 2 g of 0.042 (SE ¼ 0.017) from common coding variants was significantly different from 0 (p ¼ 7.7 3 10 À3 ; rare coding p ¼ 0:10). Moreover, the estimate of DHS enrichment from common SNPs was unaffected by the inclusion of rare coding variants (Table S24) , confirming that DHS enrichment was not an artifact of untagged coding variation in this cohort. The h 2 g from rare variants remained nonsignificant even after we partitioned according to PolyPhen-2 scores, 52 restriction to putative SP-associated genes (see Appendix A), or gene collapsing (Tables  S25 and S41-S43 ). This does not invalidate the use of collapsed-gene burden tests for association and genetic mapping because the individual collapsed gene is still a fundamentally informative unit of association. It does, however, demonstrate that the maximum variance that can be explained by such methods is guaranteed to be substantially lower than that of association with the full model, as has been shown in previous analyses of burden tests. 53 For singleton variants, we can place a 95% upper bound on collapsed h 2 g at 0.014. We caution that our exome-chip results pertain to rare variants included in the chip design (ascertained from 12,000 samples) but do not extend to extremely rare variants. However, our findings are consistent with a recent analysis of SP exome sequencing data, which identified a significant but modest rare-coding burden (0.4%-0.6% of total variance) in a subset of~2,500 genes. 54 
Fine Mapping with Functional Priors
Estimates of functional h 2 g enrichment can guide fine-mapping analysis, where the goal is to identify a minimal set of SNPs that include the underlying causal variant(s). 55 To investigate the potential benefits of fine mapping on the basis of our estimates of functional enrichment, we applied these estimates as priors for fine mapping in four traits (RA, T2D, CAD, and SP) with publicly available imputed summary statistics (Table S26 ; see Web Resources). We used corresponding estimates of functional enrichment in the WTCCC1 data for RA, T2D, and CAD (while implicitly assuming a best-case scenario in which functional enrichment was accurately estimated for each trait) and used estimates of functional enrichment in PGC2 data for SP. Given that SNPs at genome-wide-significant loci explain only a small proportion of the trait variance, we do not expect partial sample overlap to be a significant confounder. Although fine-mapping analysis ideally involves targeted sequencing or genotyping, Maller et al. 55 observed that the latter had little impact on their fine-mapping analysis in comparison to imputed data, so we expect imputed markers to be a reasonable proxy. Each locus was defined as the union of 1 Mb windows around any SNP with a p value < 5 3 10 À8 . Association statistics consisting of individual SNP effect sizes and SEs were converted to Bayes factors as described in Pickrell 13 and Wakefield 56 and were multiplied by either a flat prior or the genome-wide functional prior (computed as the estimated h 2 g per SNP of the SNP category in the corresponding trait). We then computed the credible set for each locus for each scenario by including SNP Bayes factors from highest to lowest until the sum of the Bayes factors in the set was at least 95% of the sum of the Bayes factors at the locus. On average, we found that the six main functional priors reduced the credible set of causal variants by 30% across the four traits (Table 3 ). The largest reduction of 63% was observed in RA, where the total credible set for five loci (excluding the MHC) was reduced from 69 SNPs to 26. For comparison, including only coding-variant enrichment as a prior reduced the credible sets by 5% on average and had no reduction for RA. We showed by simulation that the credible sets were well calibrated with the correct priors and miscalibrated by less than 10% when the priors were at Estimates of h 2 g (adjusted for biases due to LD; see Figure S17 and Table S23 ) are reported from variance components in the homogenous Swedish subpopulation. The top section shows estimates that include tagging of variants in other classes. The bottom section shows joint estimates accounting for tagged variance due to LD. The p values from a likelihood-ratio test are shown in parentheses.
the extremes of the meta-analysis estimates (Table S27 ), demonstrating that this functional fine-mapping strategy might become robust and effective as individual trait sample sizes reach the current meta-analysis sample size. However, we caution that our estimates of functional enrichment for individual traits, except SP, are not tight enough for this strategy to be actionable at the current time.
Discussion
The importance of regulatory and cell-type-specific variation in common disease has previously been recognized, [3] [4] [5] [6] [7] [8] [9] [10] but in contrast to previous work, we provide a quantification of this contribution to disease heritability. We have demonstrated by extensive simulations that our variance-component strategy yields robust estimates that account for LD between categories and complex-disease architecture. Across 11 traits, we found that regulatory regions marked by DHSs explained an average of 79% of imputed h 2 g and 38% of genotyped h 2 g . We replicated our results in a large SP cohort, yielding a single-trait estimate of 3.23 (SE ¼ 0.29, p ¼ 1.4 3 10 À13 ) from imputed SNPs, and found that the contribution from rare, exome-chip variants was nonsignificant and did not affect the enrichment. Given that GWASs primarily identify noncoding variants, many hypotheses have been developed to explain the architecture of complex traits, including noncoding RNA, DNA methylation, alternative splicing, and unannotated transcripts. 14, 57 Several previous studies have demonstrated an excess of significant GWAS associations in regulatory categories. 5, 6, 11, 58 DHSs (relative to noncoding SNPs) and enrichment at cell-type-relevant DHSs. In our analyzed cohorts, known variants were1.73 enriched with DHSs, but there was less enrichment at variants identified only in these cohorts. In contrast, our findings constrain most of h 2 g to the 16% of SNPs that lie in the DHS marks tested (or to SNPs that lie very close to DHSs; see below), particularly in those that overlap enhancers, and suggest that the other proposed mechanisms are unlikely to make substantial independent contributions. A deeper analysis of DHSs narrowed to cover 1% of the genome still explained 20% of h 2 g directly (and 61% in total), potentially motivating a DHS-targeted genotyping chip analogous to the exome chip. 60 More generally, our approach provides a means of assessing biological hypotheses of contributions to disease heritability. Unlike previous methods, our approach infers diseaserelevant biological function from all SNPs simultaneously instead of one GWAS hit at a time. Over multiple simulated disease architectures, we show that variance-component methods are more accurate in partitioning heritability than summary-statistic-based approaches, such as p value enrichment, despite the appeal of analyses of summary statistics in many contexts. [61] [62] [63] [64] For completeness, we also considered two additional methods, stratified Q-Q plots 12 and Bayesian hierarchical modeling (fgwas), 13 which assess functional enrichment but are primarily focused on strong associations and improving mapping power. These methods did not produce consistent estimates of h 2 g enrichment either in simulations or in real data ( Figure S19-S29 ), although we note that they have different objectives. In addition to having implications for mapping power, 12, 13, [65] [66] [67] [68] functional enrichment has direct implications for fine mapping 55, 69, 70 and risk prediction. Enrichments at the level we observed could substantially reduce the set of potential causal variants in the four traits we tested by downweighing SNPs in low-heritability categories. On the other hand, the improvement in polygenic risk prediction was limited because of pervasive LD across categories (Table S28) . Several limitations of our approach remain as avenues for future work. The variance-component method might still be subject to subtle biases 21, 41, 42 under disease architectures or annotations with complex LD structure, although our analyses indicate that it is generally less biased than published methods. In particular, we found that imputed data might lead to an overestimate of category enrichment from causal variation very close to that category. For computational reasons, we did not make use of the mixture of the normal-effect-size approach, which has been shown to increase precision. 24 The method also requires individual-level genotype data and is computationally infeasible for extremely large cohorts or a very large number of components, motivating further work on methods that analyze summary statistics. A limitation of assessing enrichment from GWAS platforms is that we cannot account for untagged causal variation, which represents roughly half of total narrow-sense heritability. 71 Although we have shown that rare coding variants are unlikely to alter the DHS enrichment, the missing heritability could lie in other categories. The precision of inferred enrichment is also limited by the underlying annotations and variants. It is possible that certain biological features could be subject to systematically poorer variant calling or imputation and exhibit decreased h 2 g as a result of artifacts, 72 although we did not observe substantial differences in the categories we analyzed. Because of the data available, our meta-analysis estimates were weighted toward autoimmune traits both in the number of individual studies and in total sample size; estimates of DHS enrichment were higher in autoimmune than in nonautoimmune traits, which could be partly due to the abundance of hematopoietic cell types in available DHS annotations. and the remaining DHS variants explained 75% of the h 2 g . We observed a slight deflation of the DHS estimate, but no significant false enrichment, at the neighboring categories ( Figure S20 ).
Jackknife Estimates of SEs
The analytical SE used for significance testing was accurate in our simulations (Table S29) and has previously been shown to be robust in real data 21, 27 but can be biased when the number of causal variants is very small. 41 We assessed this directly with a weighted-block jackknife estimate 76 of the enrichment in the real traits by dropping each chromosome in turn, constructing new GRMs, and recomputing the percentage of h 2 g for each functional category (and the corresponding enrichment). The jackknife estimate of the enrichment and its variance was then computed as described in Busing et al. 76 Although there is a demonstrable relationship between chromosome length and h 2 g , we do not expect to observe such a relationship with respect to the percentage of h 2 g because of the normalization. However, this estimate of the variance does capture true biological variation in enrichment across chromosomes and is therefore conservative. Although we observed little difference between the jackknife and standard estimates in genotyped data (Table S30) , the jackknife estimate of the imputed percentage of h 2 g (71%, SE ¼ 7.7%; Table S31 ) was indeed more conservative than the analytical estimate (79%, SE ¼ 6.6%), but the enrichment was still highly significant (p ¼ 5.5 3 10 À13 ), and the overall results were not substantially affected. Because the jackknife makes no assumptions about the underlying distribution of enrichment, this consistency with the analytical estimate supports the use of REML SEs for case-control data (see also simulations below).
Ancestry
We found little population structure in all of the traits except for MS and SP ( Figure S1 ), which have been previously reported as structured. For the MS cohort, we have shown previously 21 that rigorous ancestry matching did not substantially change the total or partitioned h 2 g . For the SP cohort, we relied on the consistently replicated enrichment across the PGC2 and Swedish SP cohorts, which have been rigorously quality controlled for the avoidance of population stratification. Recently, Janss et al. 77 demonstrated that h Case-Control Ascertainment Recent work 37, 78, 79 has shown that liability-scale estimates of h 2 g from REML can be biased downward in dichotomous traits with strong case-control ascertainment. Golan and Rosset 78 and Hayeck et al. 79 propose an alternative estimator based on Haseman-Elston (H-E) regression 80 and
show that it eliminates bias. In brief, this approach regresses the product of normalized phenotypes on the genetic covariance (off-diagonal GRM entries) for all unique pairs of samples; the resulting slope is used as an estimate of the observed-scale h 2 g and is converted to the liability scale. This method can be extended naturally to multiple components, where the product of phenotypes is regressed onto GRM entries from each analyzed component in a multiple linear regression. Here, we compared the method and transformation of Golan and Rosset 78 to the REML estimator described in the main text. We also evaluated the impact of incorporating principal components as fixed effects to account for genetic ancestry. This is particularly important for the SP and MS cohorts (see below), which were ascertained in a way that induces correlations between ancestry and phenotype. All analyses were performed with the same set of GRMs computed from 1000 Genomes imputed data, and the H-E regression (and H-E regression with fixed effects) was implemented as described in Golan and Rosset. 78 In all instances, we used analytical error-covariance estimates and rescaled them with the delta method to compute SEs. (We note that the SE for H-E regression makes strongly violated assumptions about independence, and they are therefore only presented for completeness). We observed little difference between variance-component methods and H-E regression methods, and H-E regression yielded an average estimate 1.053 greater than that of REML and an overall r 2 ¼ 0.95 between the two methods (across 11 traits; Table S32 ). The relative performance was similar when we considered only the percentage of h 2 g from the DHS component (Table  S33) such that H-E regression yielded average estimates 1.043 higher than those of REML and an overall r 2 ¼ 0.94. When principal components where included as fixed effects, meta-analysis across traits within each method did not yield significant differences (Table S34) ; H-E regression identified DHS enrichment of 5.83 (SE ¼ 0.45), and REML identified DHS enrichment of 5.13 (SE ¼ 0.42). When we did not include principal components as fixed effects, we observed a large difference between variance components and H-E regression in the SP and MS cohorts, where liability-scale H-E regression estimates of liability-scale h 2 g were 10.00 and 2.91, respectively (Table S32) , outside the plausible 0-1 bound and vastly larger than REML estimates without fixed effects. This suggests that H-E-regressionbased estimates might be particularly sensitive to the confounding effects of ancestry.
Lastly, we repeated our null simulations by using the merged WTCCC2 cohort of~33,000 samples, allowing us to simulate a case-control ascertainment (327 case and 654 control subjects) at a prevalence of 0.01 (see Table  S35 for simulation details). When we generated~1,000 samples on chromosome 1 only, this simulated cohort had an effective SNP-sample ratio (the key quantity driving the effects of case-control ascertainment 37 ) corresponding to that of~10,000 samples genome-wide. We tested a ''polygenic'' scenario where causal variants were sampled uniformly, as well as a ''high-effect'' scenario where DHS variants had 103 the effect of other SNPs, and found no significant deviation from the null estimate (Table S35) or the analytical SE (Table S36) . Although ascertainment has previously been shown to induce correlation between causal variants, our simulations indicate that this does not bias estimates of enrichment for the prevalence and sample size simulated here.
Detailed Analyses of Rare-Variant h 2 g
Having identified no significant rare-variant h 2 g at any coding regions, we were interested in quantifying this phenomenon at the set of loci known to be associated with SP. To do so, we constructed six variance components only from SNPs at the 22 loci identified by the PGC1 in a large meta-analysis 48 and estimated h 2 g jointly with a component for the remaining noncoding variants genome-wide (to account for tagging). As expected, we found the union of all noncoding GWAS variants at these loci to harbor significant heritability of 0.018 (SE ¼ 0.004) (Table S37) . However, we did not see any significant heritability from the coding variants at these classes when they were modeled jointly with the other component. This is consistent with our genome-wide finding that common noncoding variants explained a substantial fraction of trait heritability and tagged nearly half of the common coding variation. We also partitioned h 2 g at the set of 1,796 ''composite'' genes reported by Purcell et al. 54 to exhibit enrichment of rare disruptive mutations, modeled jointly with exome-chip variants in the remaining genes and noncoding GWAS-chip variants as separate components. However, no significant h We observed a significant enrichment in h 2 g at 4,919 (nonsingleton) loss-of-function variants, which collectively accounted for 6.0% of (nonsingleton) exonic SNPs but explained 24.3% of the exonic h 2 g (permuted p ¼ 0.02 after MAF matching). We saw no significant enrichment of h 2 g at coding sites that were predicted to be functionally important by PolyPhen-2. 52 Comparing likelihoods between the model where variants were split into (1) probably damaging and damaging, (2) benign and other, and (3) noncoding components and the model with only (1) coding and (2) noncoding components yielded no significant difference by a 1-degree-of-freedom likelihood-ratio test (p ¼ 0.13). 
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